Pfizer Investigator and the Head of the Neuroinflammation Re
Pfizer
Belgium
Tarek Samad, PhD, is a Pfizer Investigator and the Head of the Neuroinflammation Research Group at Pfizer’s Neuroscience Research Unit. Dr. Samad received his Master’s and PhD degrees in molecular and cellular neurobiology with a focus on dopaminergic pathways in neurodegenerative diseases, from Louis Pasteur University in Strasbourg, France. He also holds a Master’s degree in Genetic Engineering. He joined Massachusetts General Hospital and Harvard Medical School and became a faculty.
Identifies and validates therapeutic targets for innovative medicines in neurological and neurodegenerative disorders.